Alex G Hurd

Development of a gut microbe-targeted non-lethal therapeutic to inhibit thrombosis potential

S. Hazen, A. Lusis, V. Gogonea, 2018, Nature Medicine.

Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.

O. Fiehn, S. Hazen, T. Lüscher, 2018, JCI insight.

Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.

L. Räber, S. Hazen, T. Lüscher, 2019, European heart journal.

Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential

S. Hazen, A. Lusis, V. Gogonea, 2018, Nature Medicine.